15-Year Check-In: how safe is this new cell therapy for transplant patients?
NCT ID NCT05987527
First seen Jan 05, 2026 · Last updated May 01, 2026 · Updated 20 times
Summary
This study is a long-term follow-up for 11 kidney transplant patients who previously received an experimental cell therapy (CAR-Treg) designed to help the body accept the new kidney. Researchers will track safety and side effects for up to 15 years after the infusion. The goal is to understand the lasting effects of this treatment, not to test a new cure or therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erasmus MC, University Medical Center
Rotterdam, Netherlands
-
Leiden University Medical Centre
Leiden, Netherlands
-
Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom
-
University Hospitals Leuven
Leuven, Belgium
-
University Medical Center Groningen
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.